ArticleJournal of cellular and molecular medicine2021

EGCG synergizes the therapeutic effect of irinotecan through enhanced DNA damage in human colorectal cancer cells.

Wenbing Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.